When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well.
“I needed to be abreast of everything and understand everything and control everything. And I needed to hire people that would do as I requested. As the company got bigger, understood that in order to grow a big company, you needed to bring in people much better than you, who knew very well what they were doing,” Rubinsztain says.
This was one of three lessons he learned in his 20 years in running gMed, a gastroenterology electronic health record company. The second was to hire people compatible with your goals as an organization. Third, respect the culture of the corporation. Rubinsztain is taking the lessons he learned at gMed, which was acquired by Modernizing Medicine in 2015, for his next act and current gig as CEO of ChronWell.
ChronWell has created an artificial intelligence-backed platform for the workers’ compensation insurance industry. The service helps a worker injured on the job by recommending self-care, on-site care or a health care facility, it follows up with the worker and manages the claim.
Chief Executive spoke to Rubinsztain about why he’s investing in artificial intelligence at ChronWell, and speaks about the trends of consumer-driven healthcare, the lack of risks taken by the insurance industry, and non-traditional consolidation between payers and providers. Below are excerpts from this conversation.
Image Credit: Joe Rubinsztain, CEO of ChronWell
News This Week
It is the question scientists around the world are trying to answer: how long can the coronavirus survive in the tiny aerosol particles we exhale? In a high-security lab near Bristol, entered through a series [...]
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the [...]
A research team in Hungary pinched the coronavirus with a fine needle to measure how much force it could take before popping like a balloon. It did not. The native virion of Sars-CoV-2 – a [...]
Headaches, confusion and delirium experienced by some Covid-19 patients could be the result of the coronavirus directly invading the brain, according to a study published Wednesday. The research is still preliminary – but offers several [...]
By Boris M | Published in Coronavirus During the COVID-19 pandemic, there will be a lot of information about the virus and its effects on mental health. That’s because coronavirus and the social, financial and psychological [...]
A serious illness suffered by an Oxford University coronavirus vaccine trial participant was most likely “life-threatening”, a bioethics researcher says. But that doesn’t mean the clinical trials will be scrapped. AstraZeneca and Oxford University [...]
Analysis of seven trials finds dexamethasone and hydrocortisone should be given in severe cases. Studies around the world have confirmed that steroids can save lives in the Covid-19 pandemic, leading to new recommendations from [...]
Experts say strong evidence of efficacy needed to avoid approval of inferior vaccines. The rush to immunise populations against Covid-19 could lead to the rollout of a vaccine that is not very effective and [...]
The COVID-19 pandemic has dominated the news cycle for the better part of 2020. As guidelines are continually updated to reflect changes in our understanding of how the virus spreads, it is critical people [...]
Scientists in Hong Kong have reported the first confirmed case of reinfection with the coronavirus that causes Covid-19, reportedly backed up by genetic sequences of the two episodes of the 33-year-old man’s infections in March and [...]
Could uncomfortable nasal swabs be swapped for a contactless two-second breathalyzer puff to check for Covid-19 infection? Prof. Hossam Haick thinks so. Haick, a professor of chemical engineering and nanotechnology at the Technion – [...]
The relationship between antibodies for the novel coronavirus (SARS-CoV-2) and immunity, vaccine efficacy, and spread of COVID-19 has received significant attention. Dr. Seheult is back to illustrate why T cells have received less [...]
Images Description Three individuals were admitted to the hospital (ages 46–56; to men and one woman) with a multiday history of symptoms associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and underwent [...]